In addition, we found that the expression of these genes in PBMCs could be used to define three types of up-regulation: CD80 was BC-specific, CD40 and CD14 were MBC-specific, and PD-L1 and FOXP3 were linear (Fig. 4). This evidence concerns the gene CD80 and breast cancer.